lobbying_activities: 784223

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
784223	daa597b7-b5da-482d-b2fb-18b157e8fd0c	Q2	PRIME THERAPEUTICS	400339576	PRIME THERAPEUTICS	2009	second_quarter	INS	HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		106701	0	0	2009-07-09T14:32:53-04:00